Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy [0.03%]
直接抗病毒疗法出现以来丙型肝炎治疗标准的回顾性研究及良好实践总结
Jeffrey V Lazarus,Camila A Picchio,Danielle Guy et al.
Jeffrey V Lazarus et al.
Significant steps must be taken to reduce the global incidence and prevalence of hepatitis C virus (HCV) and mortality from HCV infection to achieve the WHO goal of eliminating viral hepatitis as a public health threat by 2030. Proper epide...
HBV-infection rate and long-term outcome after liver-transplantation of anti-HBc-positive liver-grafts to HBV-naïve recipients: A retrospective study [0.03%]
抗HBV阳性供肝移植到乙肝 naive受体身上的乙肝感染率及远期结果：一项回顾性研究
Daniel Hornuss,Anna Rudi,Lucas Koerner et al.
Daniel Hornuss et al.
Background: Anti-HBc only positive liver grafts may be suitable for HBV-naive recipients insofar as an appropriate infection prophylaxis is performed. Therefore, we investigated the effect of prophylactic regimens on HBV ...
Cholesterol crystals in biliary cast syndrome related to sclerosing cholangitis in critically ill patients [0.03%]
重症患者胆管硬化性胆管炎相关胆道铸型综合征胆固醇结晶
Vincent Zimmer,Matthias C Reichert,Frank Lammert
Vincent Zimmer
A tricky upper GI bleeding: Duodenal intra-diverticular angioectasia treated by endoscopic band ligation [0.03%]
胃底食道静脉曲张套扎术治疗十二指肠憩室内血管扩张一例
Vincent Zimmer,Siegfried Exner
Vincent Zimmer
The revival of preemptive UDCA therapy in liver transplant recipients: Commentary to "UDCA decreases Incidence of Primary Biliary Cholangitis and Biliary Complications after Liver Transplant: A Meta-Analysis" by Pedersen et al., Liver Transplant, November 2020 [0.03%]
熊去氧胆酸在肝移植受者中预防性治疗的复兴：对“熊去氧胆酸可降低肝移植后原发性胆汁性胆管炎和胆道并发症的发病率：一项荟萃分析”（作者：Pedersen等，Liver Transplant, November 2020）的评论
Christophe Corpechot
Christophe Corpechot
Partial major hepatectomy with cyst fenestration for polycystic liver disease: Indications, short and long-term outcomes [0.03%]
多囊肝的部分大肝切除联合肝囊肿开窗术的适应症及短期和长期疗效分析
Olivier Boillot,Bénédicte Cayot,Olivier Guillaud et al.
Olivier Boillot et al.
Background and objective: Symptomatic polycystic liver disease (PLD) with massive hepatomegaly represents a challenging surgical issue. In this work, we focused on early and long term outcomes after partial hepatectomy wi...
The dynamics of hepatitis delta virus prevalence and its potential association with hepatitis B virus vaccination [0.03%]
乙型肝炎病毒疫苗接种与丁型肝炎病毒感染流行趋势及二者潜在关联性分析
Zhijiang Miao,Yunlong Li,Peifa Yu et al.
Zhijiang Miao et al.
Japanese medlar bone in esophagus: Another set of eyes to better visualize! [0.03%]
日本梨骨滞留食道病例：多一雙眼睛，更清楚地看見！
Luca De Luca,Massimiliano Di Berardino
Luca De Luca
Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis [0.03%]
奥贝胆酸治疗肝病的疗效和安全性-系统回顾和荟萃分析
Anand V Kulkarni,Harsh Vardhan Tevethia,Juan Pablo Arab et al.
Anand V Kulkarni et al.
Background and aims: Currently, there is no pharmacotherapy for non-alcoholic steatohepatitis (NASH), a common liver disorder. In contrast, primary biliary cholangitis (PBC) is a chronic cholestatic liver disease for whic...
Circular RNA circAFF2 accelerates gastric cancer development by activating miR-6894-5p and regulating ANTXR 1 expression [0.03%]
Circular RNA circAFF2通过激活miR-6894-5p和调控ANTXR1表达来促进胃癌发生发展
Xuefeng Bu,Zhengwei Chen,Anwei Zhang et al.
Xuefeng Bu et al.
Background: Circular RNAs (circRNAs) contain a new class of non-coding RNAs that play an important role in adjusting biological function and gene expression. But the function of circRNAs in gastric cancer remains unclear....